Literature DB >> 15075994

Evaluation of a new biopsy urease test: Pronto Dry, for the diagnosis of Helicobacter pylori infection.

Rosaida Mohd Said1, Phaik-Leng Cheah, Sow-Chan Chin, Khean-Lee Goh.   

Abstract

BACKGROUND: The gastric biopsy urease test is the most frequently used test for the diagnosis of Helicobacter pylori infection in routine gastrointestinal endoscopy practice. In Malaysia up to recently, only one commercial biopsy urease test was available: the CLO test (Ballard Medical Products, Draper, Utah, USA). Large endoscopy units use their own 'homemade' unbuffered ultra rapid urease test for diagnosis of H. pylori infection.
OBJECTIVE: To compare the accuracy and reaction time of a new biopsy urease test, Pronto Dry (Medical Instruments Corporation, Solothurn, Switzerland) and the CLO test in the diagnosis of H. pylori infection.
METHODS: Consecutive patients presenting with dyspepsia to the endoscopy unit, University of Malaya Medical Centre were recruited for the study. Patients who were previously treated for H. pylori infection or who had received antibiotics, proton pump inhibitors or bismuth compounds in the preceding 4 weeks were excluded. H. pylori diagnosis was made based on the ultra rapid urease test and histological examination of gastric biopsies. Four antral and four corpus biopsies were taken for this purpose from all patients. A diagnosis of H. pylori infection was made when both the ultra rapid urease test and histology were positive in either the antral or corpus biopsies. A negative diagnosis of H. pylori was made when both tests from antral and corpus biopsies were all negative. Another four antral and four corpus biopsies (two each) were taken for the Pronto Dry and CLO tests. The Pronto Dry and CLO tests were stored and performed according to the manufacturer's instruction.
RESULTS: Two hundred and eight patients were recruited in the study. Eighty-six of the patients were males and 122 were females. The mean age was 46.3 years with a range of 15-82 years. The results for both the Pronto Dry and the CLO tests were completely concordant with sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of 98.1%, 100%, 100%, 98.1% and 99%, respectively. The Pronto Dry test showed a faster reaction time to positive compared with the CLO test, with 96.2% positive reaction by 30 min versus 70.8% and 100% positive reaction time by 55 min versus 83%. The colorimetric change was also more distinct with the Pronto Dry test compared with the CLO test.
CONCLUSIONS: Both the Pronto Dry and the CLO tests were highly accurate for the diagnosis of H. pylori infection. The Pronto Dry test showed a quicker positive reaction time and the positive colour change was more distinct.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075994     DOI: 10.1097/00042737-200402000-00012

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  16 in total

1.  Evaluation of the use of rapid urease test: Pronto Dry to detect H pylori in patients with dyspepsia in several cities in Indonesia.

Authors:  A-F Syam; M Abdullah; A-A Rani; S Nurdjanah; P Adi; A Djumhana; P Tarigan; I-D-N Wibawa
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

2.  A man with an acute abdomen.

Authors:  Ky Loh; St Kew
Journal:  Malays Fam Physician       Date:  2008-08-31

3.  Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects.

Authors:  Su Youn Nam; Bum Joon Park; Yeong-Ah Cho; Kum Hei Ryu; Il Ju Choi; Sohee Park; Young-Woo Kim
Journal:  J Gastroenterol       Date:  2016-11-15       Impact factor: 7.527

4.  Detection of Helicobacter pylori: A faster urease test can save resources.

Authors:  Andriani Koumi; Theodoros Filippidis; Vassilia Leontara; Loukia Makri; Marios Zenon Panos
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

5.  Association of current Helicobacter pylori infection and metabolic factors with gastric cancer in 35,519 subjects: A cross-sectional study.

Authors:  Su Youn Nam; Bum Joon Park; Ji Hyung Nam; Kum Hei Ryu; Myeong-Cherl Kook; Jeongseon Kim; Won Kee Lee
Journal:  United European Gastroenterol J       Date:  2018-12-12       Impact factor: 4.623

6.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

7.  Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy.

Authors:  Zaigham Abbas; Javed Yakoob; Shahab Abid; Wasim Jafri; Muhammad Islam; Zahid Azam; Imran Hilal
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

8.  Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study.

Authors:  Farzad Izadi; Aslan Ahmadi; Shadi Ghourchian; Ahmad Daneshi; Faramarz Memari; Ehsan Khadivi; Shabahang Mohammadi
Journal:  Infect Agent Cancer       Date:  2012-04-19       Impact factor: 2.965

9.  Accuracy of rapid urease test in diagnosing Helicobacter pylori infection in patients using NSAIDs.

Authors:  Mojgan Foroutan; Behnam Loloei; Shahrokh Irvani; Ezanollah Azargashb
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

10.  Are there great savings with rapid urease test by one-plus-one?

Authors:  Il Ju Choi
Journal:  Clin Endosc       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.